Thank you, Nadir. Revenues for the three months ended March 31, 2021 were $3 million, compared to $1.8 million for the comparable period in the prior year for an increase of approximately $1.2 million or 64%. This increase is primarily attributed to the sales related to the Systat and RTLS product lines. Gross profit for the three months ended March 31, 2021 was $2.1 million, compared to $1.3 million for the comparable period in the prior year for an increase of 60%. The gross profit margin for the three months ended March 31, 2021 was 70% compared to 72% for the three months ended March 31, 2020. This decrease in margin is primarily due to lower gross profit margins from the RTLS product line. Net loss attributable to stockholders of Inpixon for the three months ended March 31, 2021 was $12.6 million, compared to $6.2 million for the comparable period in the prior year. This increase in loss of approximately $6.4 million was primarily attributed to increased operating expenses, which includes $2.2 million from the Systat licensing agreement and Nanotron acquisition and approximately $4.7 million of stock-based compensation expense, which was offset by higher gross profit during the first quarter of 2021. Non-GAAP adjusted EBITDA for the three months ended March 31, 2021 was a loss of $5.6 million, compared to a loss of $3.9 million for the prior year period. Non-GAAP adjusted EBITDA is defined as net income or loss before interest provision for income taxes, depreciation and amortization plus adjustments for other income or expense items, non-recurring items, and non-cash items, including stock-based compensation. Pro forma non-GAAP net loss for basic and diluted common share for the three months ended March 31, 2021, with a loss of $0.8 per share, compared to a loss of $0.92 per share for the prior year period. Non-GAAP net loss per share is defined as net income or loss for basic and diluted share, adjusted for non-cash items including stock-based compensation, amortization of intangibles, and onetime charges and other adjustments, including loss and the exchange of debt for equity, provision for valuation allowance, on notes, and acquisition costs. As of March 31, 2021, we had an aggregate of $96.3 million income in cash on hand and short-term investments, which probably include treasury bills and treasury notes. This concludes my comments and now, I'd like to turn the call back over to Nadir.